论文部分内容阅读
目的:探讨复合凝乳酶胶囊治疗功能性消化不良(FD)的疗效。方法:采用我院2015年5月至2016年5月收治的120例FD患者,按照随机数字表法分为观察组和对照组,各60例。对照组于餐前半小时口服奥美拉唑联合莫沙必利治疗,观察组在对照组用药基础上给予复合凝乳酶胶囊。观察两组治疗效果。结果:观察组各症状评分均明显低于对照组,组间比较,差异有显著性,P<0.05;观察组治疗后胃排空率餐后30min、60min、90min及120min均明显高于对照组,组间比较,差异有显著性,P<0.05;观察组和对照组的复发率分别0和10.0%,组间比较,差异有显著性,P<0.05。结论:复合凝乳酶胶囊治疗功能性消化不良效果确切,可明显缩短胃排空时间,降低复发率。
Objective: To investigate the curative effect of compound chymosin capsule on functional dyspepsia (FD). Methods: One hundred and twenty cases of FD patients admitted to our hospital from May 2015 to May 2016 were divided into observation group and control group according to the random number table method, 60 cases each. In the control group, omeprazole and mosapride were administered orally for half an hour before meals. The observation group was given the compound chymosin capsules on the basis of the control group. Observation of two groups treatment effect. Results: The symptom scores in the observation group were significantly lower than those in the control group, the difference was significant, P <0.05; the gastric emptying rate in the observation group after 30min, 60min, 90min and 120min after meal were significantly higher than those in the control group , The difference between the two groups was significant (P <0.05). The recurrence rates of the observation group and the control group were 0 and 10.0% respectively. There was significant difference between the two groups (P <0.05). Conclusion: The compound chymosin capsule is effective in treating functional dyspepsia, which can obviously shorten the time of gastric emptying and reduce the recurrence rate.